Skip to main content
Day.News — Local News. Real Community.
MANASSAS DAY NEWS
Local News. Real Community.

National

07/20/2026 · Manassas

Full Edition

ETS Acquires ACT, Consolidating Measurement Organizations

ETS announced its acquisition of ACT, integrating two prominent organizations in educational and career assessment. The move combines their resources to address current challenges in the education sector. Officials have not disclosed the financial terms of the agreement.

07/20/2026
Read Story
Local News

State Department Introduces Commemorative Passport, Announces Streamlined Application Process

Secretary of State Marco Rubio unveiled a commemorative 'Patriot Passport' at a Washington D.C. reception, honoring the nation's 250th anniversary. The State Department also announced upcoming technological changes to simplify passport applications, including online photo uploads. These initiatives aim to enhance the passport user experience.

07/20/2026

Health

CDC Issues Warning on Frozen Blueberries Amid E. coli Outbreak

The Centers for Disease Control and Prevention announced an E. coli outbreak linked to frozen blueberries. Officials issued a recall for the affected product. Consumers should avoid eating any recalled frozen blueberries.

07/20/2026

Health

FDA Proposes Rule to Enhance Oversight of Foreign Tobacco Products

The U.S. Food and Drug Administration has proposed a new rule to strengthen its ability to identify and block illegally imported foreign tobacco products. This measure seeks to protect public health by preventing unauthorized tobacco from entering the U.S. market.

07/21/2026

Business

A Quarter of U.S. Workforce Occupies Jobs Not Requiring Formal Credentials

New findings show nearly one in four American workers hold jobs that typically require no formal educational credential. This category accounts for 37.4 million individuals in the U.S. workforce.

07/21/2026

Health

FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease

The U.S. Food and Drug Administration has granted supplemental approval for Casgevy, a gene therapy. This approval targets children aged two years and older with sickle cell disease or transfusion-dependent beta thalassemia.

07/21/2026

Advertisement

Advertisement